Bill Newell Healthcare News

This is selected healthcare news for Bill Newell, which is filed under People. There are 68 news items for this page. A press release filter page is also available for Bill Newell.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
11/23/2022 Sutro Biopharma to Participate in Upcoming Investor
SOUTH SAN FRANCISCO, Calif., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will participate in two upcoming investor conferences. Presentation Details ...
Globe Newswire
11/23/2022 Sutro Biopharma to Participate in Upcoming Investor Conferences
Sutro Biopharma, Inc. SOUTH SAN FRANCISCO, Calif., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will participate in two upcoming investor ...
Yahoo News
11/23/2022 2022-11-23 | NDAQ:STRO | Press Release | Sutro Biopharma Inc.
STRO 15 minutes ago SOUTH SAN FRANCISCO, Calif., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will participate in two upcoming ...
stockhouse.com
11/2/2022 Sutro Biopharma to Participate in Upcoming Investor
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will participate in two upcoming investor conferences. Presentation Details ...
Globe Newswire
11/2/2022 Sutro Biopharma (STRO) Sutro Biopharma to Participate in Upcoming Investor Conferences
... Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will participate in two upcoming investor conferences. Presentation Details: Credit Suisse 31st Annual Healthcare Conference Format: Presentation Date: Wednesday, November ...
researchpool.com
11/2/2022 Sutro Biopharma to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will participate in two upcoming investor conferences. Presentation Details: Credit Suisse 31st Annual Healthcare ...
biotechwinners.com
10/24/2022 Sutro Biopharma Announces Departure of Chief Medical
... be leaving the company to pursue other opportunities, effective November 4, 2022. Sutro will continue its executive search for a new CMO. In the interim, Bill Newell CEO, with support from Sutro's senior clinical development team, will oversee all clinical activities and related functions. ‚AuWe thank Arturo for his ...
Globe Newswire
10/24/2022 Sutro Biopharma Announces Departure of Chief Medical Officer
... be leaving the company to pursue other opportunities, effective November 4, 2022. Sutro will continue its executive search for a new CMO. In the interim, Bill Newell CEO, with support from Sutro's senior clinical development team, will oversee all clinical activities and related functions. ‚AuWe thank Arturo for his ...
Yahoo News
10/24/2022 2022-10-24 | NDAQ:STRO | Press Release | Sutro Biopharma Inc.
... be leaving the company to pursue other opportunities, effective November 4, 2022. Sutro will continue its executive search for a new CMO. In the interim, Bill Newell CEO, with support from Sutro’s senior clinical development team, will oversee all clinical activities and related functions. ‚AuWe thank Arturo for ...
stockhouse.com
10/24/2022 Sutro Biopharma Announces Departure of Chief Medical Officer
... be leaving the company to pursue other opportunities, effective November 4, 2022. Sutro will continue its executive search for a new CMO. In the interim, Bill Newell CEO, with support from Sutro's senior clinical development team, will oversee all clinical activities and related functions. ‚AuWe thank Arturo for his ...
biotechwinners.com
10/14/2022 why Sutro Biopharma Inc. [STRO] is a Good Choice for Investors After New Price Target of $22.62
... Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will present at the 2022 Wells Fargo Healthcare Conference on Friday, September 9, 2022, at 10:25 a.m. ET / 7:25 a.m ...
dbtnews.com
9/1/2022 Sutro Biopharma to Present at the 2022 Wells Fargo
SOUTH SAN FRANCISCO, Calif., Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will present at the 2022 Wells Fargo Healthcare Conference on Friday, September 9, 2022 ...
Globe Newswire
9/1/2022 2022-09-01 | NDAQ:STRO | Press Release | Sutro Biopharma Inc.
STRO 2 days ago SOUTH SAN FRANCISCO, Calif., Sept. 01, Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will present at the 2022 Wells Fargo Healthcare ...
stockhouse.com
9/1/2022 Sutro Biopharma to Present at the 2022 Wells Fargo Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will present at the 2022 Wells Fargo Healthcare ...
forextv.com
9/1/2022 Sutro Biopharma to Present at the 2022 Wells Fargo Healthcare Conference
... Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will present at the 2022 Wells Fargo Healthcare Conference on Friday, September 9, 2022, at 10:25 a.m. ET / 7:25 a.m ...
biotechwinners.com
6/2/2022 2022-06-02 | NDAQ:STRO | Press Release | Sutro Biopharma Inc.
... manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer therapeutics, today announced that Chief Executive Officer, Bill Newell, will participate in two upcoming investor conferences. Presentation Details: Jefferies Healthcare Conference Format: Presentation Date: Thursday, June 9, 2022 Time: 8:00 a.m. ET ...
stockhouse.com
6/2/2022 Sutro Biopharma to Participate in Upcoming Investor Conferences
... manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer therapeutics, today announced that Chief Executive Officer, Bill Newell, will participate in two upcoming investor conferences. Presentation Details: Jefferies Healthcare Conference Format: Presentation Date: Thursday, June 9, 2022 Time: 8:00 a.m. ET ...
biotechwinners.com
6/2/2022 Sutro Biopharma (STRO) Sutro Biopharma to Participate in Upcoming Investor Conferences
... manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer therapeutics, today announced that Chief Executive Officer, Bill Newell, will participate in two upcoming investor conferences. Presentation Details: Jefferies Healthcare Conference Format: Presentation Date: Thursday, June 9, 2022 Time: 8:00 a.m. ET ...
researchpool.com
4/5/2022 Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare Conference
... discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer therapeutics, today announced that Bill Newell , Chief Executive Officer, will present at the 21 st Annual Needham Virtual Healthcare Conference on Thursday, April 14, 2022 , at 3:00 p.m. ET ...
PR Newswire
3/3/2022 Sutro Biopharma to Participate in the Cowen 42nd Annual Healthcare Conference
... discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer therapeutics, today announced that Bill Newell , Chief Executive Officer, will participate in the Ovarian Cancer Panel at the Cowen 42nd Annual Healthcare Conference on Wednesday, March 9, 2022 , at ...
PR Newswire
9/1/2021 Sutro Biopharma to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
... and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced that Bill Newell , Chief Executive Officer, will participate in the 2021 Wells Fargo Securities Healthcare Conference during a virtual fireside chat on Thursday, September 9 , at ...
PR Newswire
4/20/2021 Sutro Biopharma Promotes Trevor Hallam, Ph.D., to President of Research and Chief Scientific Officer
... class compounds including STRO-001, STRO-002, CC-99712 in collaboration with Bristol Myers Squibb, and M1231 in collaboration with Merck KGaA, EMD Serono," said Bill Newell , Sutro's Chief Executive Officer. "Building on the superiority of our cell-free enabled design approach to ADCs, Sutro is expanding to other modalities ...
PR Newswire
9/21/2020 Sutro Biopharma Named Best New Drug Developer at the 7th Annual World ADC
... World ADC Digital Awards, held during the World ADC Digital Event. "We are honored to receive the World ADC Best New Drug Developer Award," said Bill Newell , Sutro's Chief Executive Officer. "The award recognizes our three innovative clinical development candidate ADCs. STRO-001 and STRO-002 are currently in Phase ...
PR Newswire
9/16/2020 Sutro Biopharma Inc (NASDAQ:STRO) Applauds The Encouraging STRO-002 Interim Phase 1 Clinical Data
... discussions in line with its ongoing Phase I dose-escalation study. Officials set to attend Some of the officials involved include the Chief Executive Officer Bill Newell, Chief Medical Officer Dr. Arturo Molina, Chief Scientific Officer Dr. Trevor Hallam, and Edward Albini, who is the company's Chief Financial Officer. These ...
biopharmajournal.com
9/3/2020 Sutro Biopharma to Present at Two Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif. Sutro Biopharma, Inc. (NASDAQ: STRO ), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, today announced that Bill Newell , Chief Executive Officer, will present at the following investor conferences ...
PR Newswire